You are here: HomeSearch
Keywords you search:
-
Description SHANGHAI, CHINA, August 13, 2020, CanSino Biologics Inc. (“CanSinoBIO”) (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoBIO will issue 24.8 million shares at the issue price of RMB209.71 per Share.
-
Description
-
Description
-
Description
-
Description
-
Description
-
Description
-
Description
-
Description
-
Description